Clinical Trial Update: Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation [NA]

View source ↗

Summary

Trial update reporting results from Campath-1H induction in primary kidney transplant recipients and its potential to allow discontinuation of calcineurin inhib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Campath-1H (alemtuzumab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Primary Renal Transplant | NA | Status: COMPLETED | Results posted: 2012-09-12